These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The chemotherapy of osteo-articular tuberculosis with recommendations for treatment of children.
    Author: Donald PR.
    Journal: J Infect; 2011 Jun; 62(6):411-39. PubMed ID: 21672650.
    Abstract:
    OBJECTIVE: To review literature regarding osteo-articular tuberculosis (OATB) and make recommendations made for the chemotherapy of children. METHODS: Key words bone tuberculosis, joint tuberculosis, tuberculosis of the spine, tuberculous osteomyelitis were used to search Pubmed and further references obtained by cross referencing and searching the indices of known papers. Results were tabulated regarding regimens, treatment duration, treatment failure, death and relapse. RESULTS: Twenty one papers described treatment of OATB with isoniazid (INH), streptomycin and para-aminosalicylic acid in 2466 patients; 2.1% failed treatment, 1.3% died due to tuberculosis (TB), 2.2% relapsed. Seventy seven papers provide details of 2950 patients receiving INH, rifampicin (RMP) and pyrazinamide (PZA) based regimens. Fifteen described six months treatment which failed in 2.5%, no patients died and 1.3% of patients followed up relapsed. Sixteen papers described 6-11 months treatment which failed in 4.3% of patients, 0.86% died due to TB and 0.86% relapsed. Forty six papers described treatment for ≥12 months; treatment failed in 0.74% of patients and death due to TB occurred in 0.84% and 0.51% relapsed. CONCLUSIONS: The majority of OATB cases in children (and adults) can be satisfactorily treated for 6 months with RMP and PZA based regimens; in spinal TB well documented cases of relapse and persistent signs of acute inflammatory response in some patients argue for caution with 6 month regimens at present. Dosages of INH (5-15 mg/kg), RMP (10-20 mg/kg), PZA (30-40 mg/kg), EMB (15-25 mg/kg) and SM (12-18 mg/kg) are recommended for treatment of children. Daily regimens are preferred.
    [Abstract] [Full Text] [Related] [New Search]